Sana Biotechnology Inc., a biotech company based in Seattle, broke ground on its new Bothell manufacturing site recently. The 80,000 square-foot facility, which will provide in-house manufacturing abilities for the company, is slated to open in 2025.
The new site replaces Sana’s previous plans to open a location in Fremont, California. A spokesperson from the biotech company expects the change in plans to save Sana more than $100 million over a three-year period.
“We have long viewed an internal manufacturing capability as core to our long-term success,” Sana CEO Steve Harr said. “This new facility enables us to continue to develop our internal manufacturing with no anticipated impact to the timing of our programs and in a more cost-effective manner.”